Clinical research of qingkailing soft capsules in treating acute upper respiratory infection
Li, C.-s.; Li, J.; Wang, X.-z.; Wang, X.-c.; Lin, X.-y.; Liu, S.-n.; Tang, X.-d.; Kong, W.-p.; Wang, S.; Shang, Y.-z.; Fan, J.; Zheng, S.-y.
Zhongguo Zhong Yao Za Zhi 30(21): 1692-1695
2005
ISSN/ISBN: 1001-5302 PMID: 16400951 Document Number: 586145
To discuss the efficacy of Qingkailing soft capsules in treating acute fever, and the relationship between symptoms-effect and time effect. Qingkailing soft capsules was taken orally, 4 times a day, 1.6 g each time. Shuanghuanglian kou fu liquid was taken as control. 129 patients with acute upper respiratory tract infection were recruited. There were 73.34% of patients cured by Qingkailing soft capsules and 43.59% cured by Shuanghuanglian kou fu liquid. The efficacy of the former was better than that of the latter (P < 0.05). The efficacy of Qingkailing soft capsules in treating Fengrexing was better than that in Fenghanxing (P < 0.05). The efficacy of Qingkailing soft capsules in reducing rapid pulse and adding moderate pulse was more remarkable than Shuanghuanglian kou fu liquid (P < 0.05). Taking Qingkailing soft capsules seldom induced mild gastrointestinal disturbance. Qingkailing soft capsules showed good result in the treatment of acute upper respiratory tract infection with less adverse effect.